Target intelligence / Profile preview

Shigella flexneri serotype 2a (S. flexneri 2a)

Target
S. flexneri 2a
01

Overview

Shigella flexneri serotype 2a is a Gram-negative, non-motile, rod-shaped bacterium in the genus Shigella. It is a major cause of shigellosis (bacillary dysentery) and is characterized by its invasive ability and diverse virulence factors[3][7][9]. The serotype "2a" refers to antigenic features of its O-antigen (part of lipopolysaccharide), which play a role in immune evasion and pathogenesis[1]. Drug resistance is increasingly common, and various molecular components of the organism (such as essential metabolic enzymes and outer membrane proteins) are targets for the development of new therapies and vaccines[2][4][6][8]. Efforts to control shigellosis focus on vaccines (targeting O-antigen or other bacterial proteins), as well as novel antimicrobial compounds that inhibit vital bacterial functions[8].

Other names
Shigella flexneri 2aS. flexneri 2aSF2a
02

Disease associations

Infection (causes shigellosis/dysentery in humans[3][7])

Beyond the preview

Go deeper on Shigella flexneri serotype 2a (S. flexneri 2a).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shigella flexneri serotype 2a (S. flexneri 2a).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call